Affiliation:
1. Transplant-Nephrology Department , University Hospital Martin , Slovakia
2. Clinic of Internal Medicine I. , University Hospital Martin and Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava , Martin , Slovakia
Abstract
Abstract
Adipocytokines are substances with endocrine functions produced by adipose tissue, playing crucial roles in regulating metabolic functions and inflammatory processes. Dysregulation of fatty tissue's endocrine functions and dysregulation of the production of adipocytokines such as adiponectin, leptin, fibroblast-stimulating factor, and others can lead to a low-grade systemic inflammation and an insulin resistance in patients. These conditions contribute to the pathophysiology of type 2 diabetes mellitus, atherosclerosis, arterial hypertension, metabolic syndrome, and other disorders. Conversely, these metabolic disorders exert feedback-regulatory effects on adipocytokines and their functions.
Glomerulonephritis encompasses a group of immune-mediated diseases characterized by inflammation of the glomeruli. Diagnosis can involve examining urine sediment, detecting autoantibodies, and identifying immune complexes in the blood. However, a kidney biopsy is required for definitive confirmation of glomerulonephritis and is considered the gold standard and a necessity in diagnosis.
Affecting the level of adipocytokines could be one of the new strategies for the pharmacological treatment of many diseases. Given a better understanding of their functions and molecular targets, adipocytokines may herald the emergence of new diagnostic approaches (1, 2). Monitoring the level of adipocytokines could contribute to a better patient management and thus become an auxiliary tool for predicting and diagnosing diseases.
Reference36 articles.
1. Fasshauer, M., Blüher, M. Adipokines in health and disease. Trends in Pharmacological Sciences [online]. 2015, 36(7), 461–470 [cit. 2021-5-25]. ISSN 01656147. Dostupné z: doi:10.1016/j.tips.2015.04.014
2. Wong, Ch. K., Cheung P. F.-Y., Lam, Ch. W. K.. Leptin-mediated cytokine release and migration of eosinophils: Implications for immunopathophysiology of allergic inflammation. European Journal of Immunology [online]. 2007, 37(8), 2337–2348 [cit. 2021-7-8]. ISSN 00142980. Dostupné z: doi:10.1002/eji.200636866
3. Nolan, E., O'meara, Y. M., Godson, C. Lipid mediators of inflammation in obesity-related glomerulopathy. Nephrology Dialysis Transplantation [online]. 2013, 28(suppl 4), iv22–iv29 [cit. 2021-5-25]. ISSN 0931-0509. Dostupné z: doi:10.1093/ndt/gft392
4. Dedinská, I, Žilinská Z. Nefrológia pre študentov lekárskych fakúlt : vysokoškolské skriptá. 1. vydanie. Martin: Jesseniova lekárska fakulta Univerzity Komenského v Martine. 2018. ISBN9788089694334.
5. Stanescu, H. C., Arcos-Burgos, M., Medlar, A., et al. Risk HLA-DQA1 and PLA 2 R1 Alleles in Idiopathic Membranous Nephropathy. New England Journal of Medicine [online]. 2011, 364(7), 616–626 [cit. 2021-7-29]. ISSN 0028-4793. Dostupné z: doi:10.1056/NEJMoa1009742